Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
causticum 200C
- Development stage
- Unknown
- Lead developer
- Fr Muller Homoeopathic Medical College
- Administration
- Oral
01
Overview
Causticum 200C is a homeopathic preparation evaluated for the treatment of primary enuresis (bedwetting) in pediatric patients. Developed and studied by Fr Muller Homoeopathic Medical College, it is prepared in a 200 centesimal potency according to the Homoeopathic Pharmacopeia of India. In a Phase 3 clinical trial (NCT02154152), the remedy was administered as globules to children aged 5-15 years. As a homeopathic treatment, its mechanism of action is based on the principle of similia similibus curentur (like cures like) rather than a conventional pharmacological target.
- Other names
- CausticumHomoeopathic Medicine causticum 200c
Beyond the preview
Go deeper on causticum 200C.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on causticum 200C.